Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 18

1.

Phosphatidylserine (PS) Is Exposed in Choroidal Neovascular Endothelium: PS-Targeting Antibodies Inhibit Choroidal Angiogenesis In Vivo and Ex Vivo.

Li T, Aredo B, Zhang K, Zhong X, Pulido JS, Wang S, He YG, Huang X, Brekken RA, Ufret-Vincenty RL.

Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7137-45. doi: 10.1167/iovs.15-17302.

PMID:
26529048
2.

Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial.

Kuppermann BD, Goldstein M, Maturi RK, Pollack A, Singer M, Tufail A, Weinberger D, Li XY, Liu CC, Lou J, Whitcup SM; Ozurdex® ERIE Study Group.

Ophthalmologica. 2015;234(1):40-54. doi: 10.1159/000381865. Epub 2015 Jun 18.

3.

A chimeric Cfh transgene leads to increased retinal oxidative stress, inflammation, and accumulation of activated subretinal microglia in mice.

Aredo B, Li T, Chen X, Zhang K, Wang CX, Gou D, Zhao B, He Y, Ufret-Vincenty RL.

Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3427-40. doi: 10.1167/iovs.14-16089.

4.

Differences in the distribution, phenotype and gene expression of subretinal microglia/macrophages in C57BL/6N (Crb1 rd8/rd8) versus C57BL6/J (Crb1 wt/wt) mice.

Aredo B, Zhang K, Chen X, Wang CX, Li T, Ufret-Vincenty RL.

J Neuroinflammation. 2015 Jan 15;12:6. doi: 10.1186/s12974-014-0221-4.

5.

Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates.

van der Veen S, Johnson S, Jongerius I, Malik T, Genovese A, Santini L, Staunton D, Ufret-Vincenty RL, Pickering MC, Lea SM, Tang CM.

Infect Immun. 2014 Mar;82(3):1157-63. doi: 10.1128/IAI.01183-13. Epub 2013 Dec 30.

6.

Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence.

Gustafsson MC, Lannergård J, Nilsson OR, Kristensen BM, Olsen JE, Harris CL, Ufret-Vincenty RL, Stålhammar-Carlemalm M, Lindahl G.

PLoS Pathog. 2013;9(4):e1003323. doi: 10.1371/journal.ppat.1003323. Epub 2013 Apr 18.

7.

Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2).

Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd; AREDS2 Study Group.

Invest Ophthalmol Vis Sci. 2013 Jul 8;54(7):4548-54. doi: 10.1167/iovs.13-11804.

8.

Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.

Johnson S, Tan L, van der Veen S, Caesar J, Goicoechea De Jorge E, Harding RJ, Bai X, Exley RM, Ward PN, Ruivo N, Trivedi K, Cumber E, Jones R, Newham L, Staunton D, Ufret-Vincenty R, Borrow R, Pickering MC, Lea SM, Tang CM.

PLoS Pathog. 2012;8(10):e1002981. doi: 10.1371/journal.ppat.1002981. Epub 2012 Oct 25. Erratum in: PLoS Pathog. 2013 Jan;9(1). doi: 10.1371/annotation/3e7e6415-fb12-4a87-89e6-f87d2e800ba8.

9.

Novel method for the rapid isolation of RPE cells specifically for RNA extraction and analysis.

Xin-Zhao Wang C, Zhang K, Aredo B, Lu H, Ufret-Vincenty RL.

Exp Eye Res. 2012 Sep;102:1-9. doi: 10.1016/j.exer.2012.06.003. Epub 2012 Jun 18.

10.

Next-generation therapeutic solutions for age-related macular degeneration.

Cunnusamy K, Ufret-Vincenty R, Wang S.

Pharm Pat Anal. 2012 May;1(2):193-206. Review.

11.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group, Li J.

Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014. Epub 2011 Jul 20.

PMID:
21764136
12.

Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters.

Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S.

Proc Natl Acad Sci U S A. 2011 May 17;108(20):8287-92. doi: 10.1073/pnas.1105254108. Epub 2011 May 2.

13.

Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings.

Ufret-Vincenty RL, Aredo B, Liu X, McMahon A, Chen PW, Sun H, Niederkorn JY, Kedzierski W.

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5878-87. doi: 10.1167/iovs.09-4457. Epub 2010 Jun 10.

PMID:
20538999
14.

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group.

Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24.

PMID:
20417567
15.

Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant.

Ufret-Vincenty RL, Singh RP, Lowder CY, Kaiser PK.

Am J Ophthalmol. 2007 Feb;143(2):334-5. Epub 2006 Oct 23.

PMID:
17258523
16.

Endophthalmitis after 25-gauge transconjunctival sutureless vitrectomy.

Taban M, Ufret-Vincenty RL, Sears JE.

Retina. 2006 Sep;26(7):830-1. No abstract available.

PMID:
16963862
17.

Photosensitizers in photodynamic therapy of choroidal neovascularization.

Ufret-Vincenty RL, Miller JW, Gragoudas ES.

Int Ophthalmol Clin. 2004 Summer;44(3):63-80. Review. No abstract available.

PMID:
15211178
18.

Corneal flap displacement and drift in LASIK: comparison of Hansatome and Automated Corneal Shaper microkeratomes.

Ufret-Vincenty RL, Jiunn-Liang Chen R, Azar DT.

Am J Ophthalmol. 2002 Nov;134(5):701-6.

PMID:
12429246
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk